NSETrading Window28 Sept 2026 · 28 Sept 2026, 02:51 pm
Trading Window
Indoco Remedies Limited · INDOCO
✦ AI Summary
Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will remain closed from 01st October, 2026 until 48 hours after the declaration of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
INDOCO_28092026145106_Closure_of_TW_QE_30092026.pdf
View document text
Date:- 28th September, 2026
To To
The Listing Department The Listing Department
National Stock Exchange of India Limited Bombay Stock Exchange Limited
Exchange Plaza, Floor 25, P. J.
Bandra – Kurla Complex Towers, Dalal Street,
Bandra (East) Mumbai – 400 001
Mumbai – 400 051 Stock Code : 532612
Stock Code : INDOCO
Dear Sir/Madam,
Sub: Intimation regarding Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and
Company’s code of conduct for regulating, monitoring and reporting of trading by
insiders, this is to inform you that the Trading Window for trading/dealing in Equity
Shares of the Company will remain closed from Thursday, 01st October, 2026 until 48
hours after declaration of Unaudited Standalone and Consolidated Financial Results of
the Company for the Quarter and Half Year Ended 30th September, 2026. During the
closure of trading window, all designated persons of the Company (including their
immediate relatives) have been advised not to deal in Equity Shares of the Company.
The date of the Board Meeting of the Company for declaration of Unaudited Standalone
and Consolidated Financial Results for the Quarter and Half Year Ended 30th September,
2026, will be intimated in due course.
You are requested to kindly take the same on record
Thanking you,
Yours faithfully,
For Indoco Remedies Limited
Ramanathan Hariharan
Company Secretary & Head Legal